Report Summary
Eternity Insights has published a new study on Global Active Pharma Ingredient Market focusing on key segments By Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients, Other), By Application (Oncology, Cardiovascular Disease, Diabetes, Central Nervous System And Neurological Disorders, Endocrinology, Other), and by region. This deep dive research report highlights the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Active Pharma Ingredient Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Active Pharma Ingredient Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Active Pharma Ingredient Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Active Pharma Ingredient Market Segmentation:
Active Pharma Ingredient Market, By Type
- Innovative Active Pharmaceutical Ingredients
- Generic Active Pharmaceutical Ingredients
- Other
Active Pharma Ingredient Market, By Application
- Oncology
- Cardiovascular Disease
- Diabetes
- Central Nervous System and Neurological Disorders
- Endocrinology
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Active Pharma Ingredient market in terms of demand generation. The Active Pharma Ingredient market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Active Pharma Ingredient market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Active Pharma Ingredient Market Taxonomy:
To learn more about this report
Global Active Pharma Ingredient Market Competitive Landscape
The global Active Pharma Ingredient market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Biocon
- Lonza group
- Novartis
- Dr. Reddy's Laboratories
- North East Pharmaceutical
- Boehringer Ingelheim GmbH
- Johnson Matthey
- North China Pharmaceutical Group
- Albemarle
- Roche
- Aurobindo pharma
- Tian Yao
- Bayer
- DSM
- Sun Pharmaceutical Industries
- Cambrex
- Shandong Lukang Pharmaceutical
- Jiangsu Hengrui Medicine
- Johnson & Johnson
- Hisun Pharmacy
- BASF
- Huahai Pharmaceutical
- Mylan
- Pfizer
- Shandong Xinhua Pharmaceutical
- Haerbin Pharmaceutical Group
- Lupin
- Cipla
- Teva
- Zhejiang Medicine
- Other Players of Specific Interest can be added based on the requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Innovative Active Pharmaceutical Ingredients,Generic Active Pharmaceutical Ingredients, Other |
| By Application Outlook |
Oncology, Cardiovascular Disease, Diabetes, Central Nervous System and Neurological Disorders, Endocrinology, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Biocon,Lonza group,Novartis,Dr. Reddy's Laboratories, North East Pharmaceutical, Boehringer Ingelheim GmbH, Johnson Matthey, North China Pharmaceutical Group, Albemarle, Roche, Aurobindo pharma, Tian Yao, Bayer, DSM, Sun Pharmaceutical Industries,Cambrex, Shandong Lukang Pharmaceutical, Jiangsu Hengrui Medicine, Johnson & Johnson, Hisun Pharmacy, BASF,Huahai Pharmaceutical, Mylan,Pfizer, Shandong Xinhua Pharmaceutical, Haerbin Pharmaceutical Group, Lupin,Cipla, Teva, Zhejiang Medicine |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stakeholders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Global Active Pharma Ingredient Industry Market Research Report
1 Active Pharma Ingredient Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Active Pharma Ingredient
1.3 Active Pharma Ingredient Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Active Pharma Ingredient Value ($) and Growth Rate from 2014-2026
1.4 Market Segmentation
1.4.1 Types of Active Pharma Ingredient
1.4.2 Applications of Active Pharma Ingredient
1.4.3 Research Regions
1.4.3.1 North America Active Pharma Ingredient Production Value ($) and Growth Rate (2014-2019)
1.4.3.2 Europe Active Pharma Ingredient Production Value ($) and Growth Rate (2014-2019)
1.4.3.3 China Active Pharma Ingredient Production Value ($) and Growth Rate (2014-2019)
1.4.3.4 Japan Active Pharma Ingredient Production Value ($) and Growth Rate (2014-2019)
1.4.3.5 Middle East & Africa Active Pharma Ingredient Production Value ($) and Growth Rate (2014-2019)
1.4.3.6 India Active Pharma Ingredient Production Value ($) and Growth Rate (2014-2019)
1.4.3.7 South America Active Pharma Ingredient Production Value ($) and Growth Rate (2014-2019)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Active Pharma Ingredient
1.5.1.2 Growing Market of Active Pharma Ingredient
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Active Pharma Ingredient Analysis
2.2 Major Players of Active Pharma Ingredient
2.2.1 Major Players Manufacturing Base and Market Share of Active Pharma Ingredient in 2018
2.2.2 Major Players Product Types in 2018
2.3 Active Pharma Ingredient Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Active Pharma Ingredient
2.3.3 Raw Material Cost of Active Pharma Ingredient
2.3.4 Labor Cost of Active Pharma Ingredient
2.4 Market Channel Analysis of Active Pharma Ingredient
2.5 Major Downstream Buyers of Active Pharma Ingredient Analysis
3 Global Active Pharma Ingredient Market, by Type
3.1 Global Active Pharma Ingredient Value ($) and Market Share by Type (2014-2019)
3.2 Global Active Pharma Ingredient Production and Market Share by Type (2014-2019)
3.3 Global Active Pharma Ingredient Value ($) and Growth Rate by Type (2014-2019)
3.4 Global Active Pharma Ingredient Price Analysis by Type (2014-2019)
4 Active Pharma Ingredient Market, by Application
4.1 Global Active Pharma Ingredient Consumption and Market Share by Application (2014-2019)
4.2 Downstream Buyers by Application
4.3 Global Active Pharma Ingredient Consumption and Growth Rate by Application (2014-2019)
5 Global Active Pharma Ingredient Production, Value ($) by Region (2014-2019)
5.1 Global Active Pharma Ingredient Value ($) and Market Share by Region (2014-2019)
5.2 Global Active Pharma Ingredient Production and Market Share by Region (2014-2019)
5.3 Global Active Pharma Ingredient Production, Value ($), Price and Gross Margin (2014-2019)
5.4 North America Active Pharma Ingredient Production, Value ($), Price and Gross Margin (2014-2019)
5.5 Europe Active Pharma Ingredient Production, Value ($), Price and Gross Margin (2014-2019)
5.6 China Active Pharma Ingredient Production, Value ($), Price and Gross Margin (2014-2019)
5.7 Japan Active Pharma Ingredient Production, Value ($), Price and Gross Margin (2014-2019)
5.8 Middle East & Africa Active Pharma Ingredient Production, Value ($), Price and Gross Margin (2014-2019)
5.9 India Active Pharma Ingredient Production, Value ($), Price and Gross Margin (2014-2019)
5.10 South America Active Pharma Ingredient Production, Value ($), Price and Gross Margin (2014-2019)
6 Global Active Pharma Ingredient Production, Consumption, Export, Import by Regions (2014-2019)
6.1 Global Active Pharma Ingredient Consumption by Regions (2014-2019)
6.2 North America Active Pharma Ingredient Production, Consumption, Export, Import (2014-2019)
6.3 Europe Active Pharma Ingredient Production, Consumption, Export, Import (2014-2019)
6.4 China Active Pharma Ingredient Production, Consumption, Export, Import (2014-2019)
6.5 Japan Active Pharma Ingredient Production, Consumption, Export, Import (2014-2019)
6.6 Middle East & Africa Active Pharma Ingredient Production, Consumption, Export, Import (2014-2019)
6.7 India Active Pharma Ingredient Production, Consumption, Export, Import (2014-2019)
6.8 South America Active Pharma Ingredient Production, Consumption, Export, Import (2014-2019)
7 Global Active Pharma Ingredient Market Status and SWOT Analysis by Regions
7.1 North America Active Pharma Ingredient Market Status and SWOT Analysis
7.2 Europe Active Pharma Ingredient Market Status and SWOT Analysis
7.3 China Active Pharma Ingredient Market Status and SWOT Analysis
7.4 Japan Active Pharma Ingredient Market Status and SWOT Analysis
7.5 Middle East & Africa Active Pharma Ingredient Market Status and SWOT Analysis
7.6 India Active Pharma Ingredient Market Status and SWOT Analysis
7.7 South America Active Pharma Ingredient Market Status and SWOT Analysis
8 Competitive Landscape
8.1 Competitive Profile
8.2 Biocon
8.2.1 Company Profiles
8.2.2 Active Pharma Ingredient Product Introduction
8.2.3 Biocon Production, Value ($), Price, Gross Margin 2014-2019
8.2.4 Biocon Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.3 Lonza group
8.3.1 Company Profiles
8.3.2 Active Pharma Ingredient Product Introduction
8.3.3 Lonza group Production, Value ($), Price, Gross Margin 2014-2019
8.3.4 Lonza group Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.4 Novartis
8.4.1 Company Profiles
8.4.2 Active Pharma Ingredient Product Introduction
8.4.3 Novartis Production, Value ($), Price, Gross Margin 2014-2019
8.4.4 Novartis Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.5 Dr. Reddy's Laboratories
8.5.1 Company Profiles
8.5.2 Active Pharma Ingredient Product Introduction
8.5.3 Dr. Reddy's Laboratories Production, Value ($), Price, Gross Margin 2014-2019
8.5.4 Dr. Reddy's Laboratories Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.6 North East Pharmaceutical
8.6.1 Company Profiles
8.6.2 Active Pharma Ingredient Product Introduction
8.6.3 North East Pharmaceutical Production, Value ($), Price, Gross Margin 2014-2019
8.6.4 North East Pharmaceutical Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.7 Boehringer Ingelheim GmbH
8.7.1 Company Profiles
8.7.2 Active Pharma Ingredient Product Introduction
8.7.3 Boehringer Ingelheim GmbH Production, Value ($), Price, Gross Margin 2014-2019
8.7.4 Boehringer Ingelheim GmbH Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.8 Johnson Matthey
8.8.1 Company Profiles
8.8.2 Active Pharma Ingredient Product Introduction
8.8.3 Johnson Matthey Production, Value ($), Price, Gross Margin 2014-2019
8.8.4 Johnson Matthey Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.9 North China Pharmaceutical Group
8.9.1 Company Profiles
8.9.2 Active Pharma Ingredient Product Introduction
8.9.3 North China Pharmaceutical Group Production, Value ($), Price, Gross Margin 2014-2019
8.9.4 North China Pharmaceutical Group Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.10 Albemarle
8.10.1 Company Profiles
8.10.2 Active Pharma Ingredient Product Introduction
8.10.3 Albemarle Production, Value ($), Price, Gross Margin 2014-2019
8.10.4 Albemarle Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.11 Roche
8.11.1 Company Profiles
8.11.2 Active Pharma Ingredient Product Introduction
8.11.3 Roche Production, Value ($), Price, Gross Margin 2014-2019
8.11.4 Roche Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.12 Aurobindo pharma
8.12.1 Company Profiles
8.12.2 Active Pharma Ingredient Product Introduction
8.12.3 Aurobindo pharma Production, Value ($), Price, Gross Margin 2014-2019
8.12.4 Aurobindo pharma Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.13 Tian Yao
8.13.1 Company Profiles
8.13.2 Active Pharma Ingredient Product Introduction
8.13.3 Tian Yao Production, Value ($), Price, Gross Margin 2014-2019
8.13.4 Tian Yao Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.14 Bayer
8.14.1 Company Profiles
8.14.2 Active Pharma Ingredient Product Introduction
8.14.3 Bayer Production, Value ($), Price, Gross Margin 2014-2019
8.14.4 Bayer Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.15 DSM
8.15.1 Company Profiles
8.15.2 Active Pharma Ingredient Product Introduction
8.15.3 DSM Production, Value ($), Price, Gross Margin 2014-2019
8.15.4 DSM Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.16 Sun Pharmaceutical Industries
8.16.1 Company Profiles
8.16.2 Active Pharma Ingredient Product Introduction
8.16.3 Sun Pharmaceutical Industries Production, Value ($), Price, Gross Margin 2014-2019
8.16.4 Sun Pharmaceutical Industries Market Share of Active Pharma Ingredient Segmented by Region in 2018
8.17 Cambrex
8.18 Shandong Lukang Pharmaceutical
8.19 Jiangsu Hengrui Medicine
8.20 Johnson & Johnson
8.21 Hisun Pharmacy
8.22 BASF
8.23 Huahai Pharmaceutical
8.24 Mylan
8.25 Pfizer
8.26 Shandong Xinhua Pharmaceutical
8.27 Haerbin Pharmaceutical Group
8.28 Lupin
8.29 Cipla
8.30 Teva
8.31 Zhejiang Medicine
9 Global Active Pharma Ingredient Market Analysis and Forecast by Type and Application
9.1 Global Active Pharma Ingredient Market Value ($) & Volume Forecast, by Type (2019-2026)
9.1.1 Innovative Active Pharmaceutical Ingredients Market Value ($) and Volume Forecast (2019-2026)
9.1.2 Generic Active Pharmaceutical Ingredients Market Value ($) and Volume Forecast (2019-2026)
9.2 Global Active Pharma Ingredient Market Value ($) & Volume Forecast, by Application (2019-2026)
9.2.1 Oncology Market Value ($) and Volume Forecast (2019-2026)
9.2.2 Cardiovascular Disease Market Value ($) and Volume Forecast (2019-2026)
9.2.3 Diabetes Market Value ($) and Volume Forecast (2019-2026)
9.2.4 Central Nervous System and Neurological Disorders Market Value ($) and Volume Forecast (2019-2026)
9.2.5 Endocrinology Market Value ($) and Volume Forecast (2019-2026)
9.2.6 Other Therapeutic Applications Market Value ($) and Volume Forecast (2019-2026)
10 Active Pharma Ingredient Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2019-2026)
10.2 Europe Market Value ($) and Consumption Forecast (2019-2026)
10.3 China Market Value ($) and Consumption Forecast (2019-2026)
10.4 Japan Market Value ($) and Consumption Forecast (2019-2026)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2019-2026)
10.6 India Market Value ($) and Consumption Forecast (2019-2026)
10.7 South America Market Value ($) and Consumption Forecast (2019-2026)
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Research Finding and Conclusion
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
